SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is experiencing heightened interest following a recent surge in trading volume and new exchange listings, complemented by a significant slowdown in token dilution that is reducing selling pressure. Community discussions are vibrant, with many anticipating substantial 'altseason' gains for the Layer 1 network, citing its AI-integrated exchange and cross-chain bridging technology as core utilities while debating its perceived undervaluation and past tokenomics.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is drawing significant attention following its Coinbase listing and a pivotal bank acquisition, which positions the crypto for compliant, high-speed financial settlements. The community is highly bullish, citing Keeta's verified rapid transaction speeds and endorsements from influential figures like Google's former CEO as key factors for its potential to revolutionize global finance and real-world asset tokenization.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin (SWFTC) is actively trending amid widespread community excitement, primarily driven by persistent rumors of new major exchange listings, notably Coinbase, and noticeable increases in trading volume. The community is emphasizing its core utility, including an AI-integrated exchange and crucial cross-chain bridging technology, with many anticipating substantial 'altseason' gains while highlighting its fully diluted supply and perceived undervaluation within the evolving multi-chain crypto landscape.

Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is trending with significant bullish sentiment driven by a series of positive clinical updates, including encouraging early data from its ALS program and sustained efficacy in its Wolfram syndrome treatment. The community is actively discussing the robust Phase 2 results for its post-bariatric hypoglycemia drug and the broader potential of its ASO platform. This pipeline momentum, combined with increasing institutional interest and ongoing M&A speculation in the biotech sector, positions the company as a key topic of conversation.

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A

Fortress Biotech's preferred shares ($FBIOP) are trending as the community intensely debates the imminent sale of a Priority Review Voucher (PRV) following recent FDA approval of CUTX-101. Investors are actively crunching numbers on the PRV's potential proceeds, widely believing this event, alongside growing revenues from assets like Emrosi and Unloxcyt, will significantly de-risk the company and prompt dividend reinstatement for $FBIOP. This focus on financial stability and capital structure is fueling discussions about the preferred shares' perceived undervaluation and the need for clearer communication from Fortress management.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

SWEAT Crypto is trending amidst community discussions highlighting its potential for future growth, with recent token burns and its expanding role as a universal gas token for blockchain transactions capturing attention. Investors are focusing on its move-to-earn model, where verified physical activity earns rewards, driving utility through new Web3 games and staking opportunities within its ecosystem.

Mission Produce, Inc. engages in farming, packaging, marketing, and distribution of avocados to food retailers, distributors, and produce wholesalers worldwide. It operates through the following segments: Marketing and Distribution, International Farming, and Blueberries. The Marketing and Distribution segment focuses on sourcing fruit from growers and distributes the fruit through its global distribution network. The International Farming segment includes ownership and operation of orchards. The Blueberries segment focuses on farming activities which includes early-stage blueberry plantation and harvesting of mature bushes. The company was founded by Stephen J. Barnard and Ed Williams in 1983 and is headquartered in Oxnard, CA.

Mission Produce Inc

Mission Produce is generating significant buzz following its substantial acquisition of Calavo Growers and a recent impressive earnings beat. The community is actively discussing how the company's strong operational execution, expanding global platform, and strategic diversification into other fruits are driving market outperformance. Investors are now focused on AVO's sustained momentum and margin discipline within the dynamic fresh produce sector.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is heavily trending ahead of the highly anticipated release of 3-year functional results for its gene therapy, ELEVIDYS, from the EMBARK study. The community is buzzing with expectations of a significant positive market response and potential short squeeze, though some remain wary of past market reactions to company events. Amid discussions of pipeline progress and perceived undervaluation, investors are closely watching for catalysts in its rare disease portfolio.

American Tower Corp. provides real estate investment services, and owns, operates, and develops multi-tenant real estate properties. It offers leasing of space on communications sites to wireless service providers, radio and television broadcast companies. The firm operates through the following segments: U.S. and Canada, Africa and APAC, Europe, Latin America, and Data Centers, and Services. The company was founded in 1995 and is headquartered in Boston, MA.

American Tower Corp.

American Tower is trending as its CoreSite data center business actively expands to support high-bandwidth digital infrastructure and AI adoption, with new facilities and cloud partnerships driving conversation. The community is closely monitoring its performance as a large-cap tower REIT, anticipating a potential re-rating as interest rate expectations evolve, while also noting strategic portfolio adjustments like the recent divestment of international operations. It remains a benchmark for established telecom infrastructure, often compared to emerging, high-volatility players.

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Exact Sciences Corp.

Exact Sciences is trending following an acquisition offer from Abbott Laboratories at $105 per share, valuing the company at approximately $21-23 billion. The community is actively debating whether this offer price fully captures the company's value, with many long-term holders reflecting on significant gains while considering reinvestment elsewhere due to the deal's cap and anticipated 2026 closure. This strategic acquisition signifies a major consolidation, aiming to create a cancer-screening giant within the diagnostics sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NFLX can this poor turd run a bit next week as am betting some calls strike 87$ ? Anything can help the stock as WAR bid still long weeks  to go

Keith

StockTwits Web

Netflix Inc

 can this poor turd run a bit next week as am betting some calls strike 87$ ? Anything can help the stock as WAR bid still long weeks  to go